These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33106327)

  • 1. Modulating the endoplasmic reticulum stress response attenuates neurodegeneration in a
    Doyle JJ; Vrancx C; Maios C; Labarre A; Patten SA; Parker JA
    Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33106327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.
    Hensel N; Cieri F; Santonicola P; Tapken I; Schüning T; Taiana M; Pagliari E; Joseph A; Fischer S; Heidrich N; Brinkmann H; Kubinski S; Bergmann AK; Richter MF; Jung K; Corti S; Di Schiavi E; Claus P
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33931501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds.
    Sleigh JN; Buckingham SD; Esmaeili B; Viswanathan M; Cuppen E; Westlund BM; Sattelle DB
    Hum Mol Genet; 2011 Jan; 20(2):245-60. PubMed ID: 20962036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing GABAergic Transmission Improves Locomotion in a
    Wu CY; Gagnon DA; Sardin JS; Barot U; Telenson A; Arratia PE; Kalb RG
    eNeuro; 2018; 5(6):. PubMed ID: 30627660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.
    Miller N; Feng Z; Edens BM; Yang B; Shi H; Sze CC; Hong BT; Su SC; Cantu JA; Topczewski J; Crawford TO; Ko CP; Sumner CJ; Ma L; Ma YC
    J Neurosci; 2015 Apr; 35(15):6038-50. PubMed ID: 25878277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB; Kothary R; Parks RJ
    Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of ATXN3 neuronal toxicity in
    Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA
    Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
    Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J
    Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms and animal models of spinal muscular atrophy.
    Edens BM; Ajroud-Driss S; Ma L; Ma YC
    Biochim Biophys Acta; 2015 Apr; 1852(4):685-92. PubMed ID: 25088406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.
    Riessland M; Kaczmarek A; Schneider S; Swoboda KJ; Löhr H; Bradler C; Grysko V; Dimitriadi M; Hosseinibarkooie S; Torres-Benito L; Peters M; Upadhyay A; Biglari N; Kröber S; Hölker I; Garbes L; Gilissen C; Hoischen A; Nürnberg G; Nürnberg P; Walter M; Rigo F; Bennett CF; Kye MJ; Hart AC; Hammerschmidt M; Kloppenburg P; Wirth B
    Am J Hum Genet; 2017 Feb; 100(2):297-315. PubMed ID: 28132687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
    de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
    Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM; Blanco-Redondo B; Buettner JM; Pagiazitis JG; Fletcher EV; Sime Longang JK; Mentis GZ
    J Neurosci; 2021 Jan; 41(2):376-389. PubMed ID: 33219005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific knock-down of SMN1 causes neuron degeneration and death through an apoptotic mechanism.
    Gallotta I; Mazzarella N; Donato A; Esposito A; Chaplin JC; Castro S; Zampi G; Battaglia GS; Hilliard MA; Bazzicalupo P; Di Schiavi E
    Hum Mol Genet; 2016 Jun; 25(12):2564-2577. PubMed ID: 27260405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
    Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
    Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy.
    Hor JH; Soh ES; Tan LY; Lim VJW; Santosa MM; Winanto ; Ho BX; Fan Y; Soh BS; Ng SY
    Cell Death Dis; 2018 Oct; 9(11):1100. PubMed ID: 30368521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
    Mole AJ; Bell S; Thomson AK; Dissanayake KN; Ribchester RR; Murray LM
    J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.
    Briese M; Esmaeili B; Fraboulet S; Burt EC; Christodoulou S; Towers PR; Davies KE; Sattelle DB
    Hum Mol Genet; 2009 Jan; 18(1):97-104. PubMed ID: 18829666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.